Sex differences in the toxicokinetics of inhaled solvent vaporsin humans -: 1.: m-xylene

被引:13
作者
Ernstgård, L [1 ]
Sjögren, B [1 ]
Warholm, M [1 ]
Johanson, G [1 ]
机构
[1] Karolinska Inst, Inst Environm Med, SE-17177 Stockholm, Sweden
关键词
human; sex; toxicokinetics; m-xylene; genotype; inhalation; organic solvent;
D O I
10.1016/j.taap.2003.08.004
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The aim of this study was to evaluate possible sex differences in the inhalation toxicokinetics of m-xylene vapor. Seventeen healthy volunteers (nine women and eight men) were exposed to m-xylene (200 mg/m(3)) and to clean air (control exposure) on different occasions during 2 h of light physical exercise (50 W). The chosen level corresponds to the occupational exposure limit (8-h time weighted average) in Sweden. m-Xylene was monitored up to 24 h after exposure in exhaled air, blood, saliva, and urine by headspace gas chromatography. m-Methyl hipp uric acid (a metabolite of m-xylene) was analyzed in urine by high-performance liquid chromatography. Body fat and lean body mass (LBM) were estimated from sex-specific equations using bioelectrical impedance, body weight, height, and age. Genotypes and/or phenotypes of cytochromes P450 2El and 1Al, glutathione transferases M1 and P1, and epoxide hydrolase were determined. The toxicokinetic profile in blood was analyzed using a two-compartment population model. The area under the concentration-time curve (AUC) of m-xylene in exhaled air postexposure was larger in women than in men. In addition, the excretion via exhaled air was significantly higher in women when correcting for body weight or LBM. In contrast, the men had a significantly higher volume of distribution, excretion of m-methylhippuric acid in urine, and AUC of m-xylene in urine. The toxicokinetic analyses revealed no differences between subjects of different metabolic genotypes or phenotypes. In conclusion, the study indicates small sex differences in the inhalation toxicokinetics of in-xylene, which can be explained by body build. (C) 2003 Elsevier Inc. All rights reserved.
引用
收藏
页码:147 / 157
页数:11
相关论文
共 43 条
[21]  
JONSSON EN, 1997, XPOSE 2 0 USERS MANU
[22]   EFFECTS OF ALDH2, CYP1A1, AND CYP2E1 GENETIC POLYMORPHISMS AND SMOKING AND DRINKING HABITS ON TOLUENE METABOLISM IN HUMANS [J].
KAWAMOTO, T ;
KOGA, M ;
MURATA, K ;
MATSUDA, S ;
KODAMA, Y .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 1995, 133 (02) :295-304
[23]   INTERINDIVIDUAL VARIABILITY OF CHLORZOXAZONE 6-HYDROXYLATION IN MEN AND WOMEN AND ITS RELATIONSHIP TO CYP2E1 GENETIC POLYMORPHISMS [J].
KIM, RB ;
OSHEA, D ;
WILKINSON, GR .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1995, 57 (06) :645-655
[24]  
Le Marchand L, 1999, CANCER EPIDEM BIOMAR, V8, P495
[25]   Cytochrome P-4502E1: Its physiological and pathological role [J].
Lieber, CS .
PHYSIOLOGICAL REVIEWS, 1997, 77 (02) :517-544
[26]   CYTOCHROME-P450 2E1 GENOTYPE AND CHLORZOXAZONE METABOLISM IN HEALTHY AND ALCOHOLIC CAUCASIAN SUBJECTS [J].
LUCAS, D ;
MENEZ, C ;
GIRRE, C ;
BERTHOU, F ;
BODENEZ, P ;
JOANNET, I ;
HISPARD, E ;
BARDOU, LG ;
MENEZ, JF .
PHARMACOGENETICS, 1995, 5 (05) :298-304
[27]  
Maughan R J, 1993, Br J Sports Med, V27, P63
[28]   A genetic polymorphism in the regulatory sequences of human CYP2E1:: Association with increased chlorzoxazone hydroxylation in the presence of obesity and ethanol intake [J].
McCarver, DG ;
Byun, R ;
Hines, RN ;
Hichme, M ;
Wegenek, W .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 1998, 152 (01) :276-281
[29]   A SIMPLE SALTING OUT PROCEDURE FOR EXTRACTING DNA FROM HUMAN NUCLEATED CELLS [J].
MILLER, SA ;
DYKES, DD ;
POLESKY, HF .
NUCLEIC ACIDS RESEARCH, 1988, 16 (03) :1215-1215
[30]  
Nihlén A, 1998, TOXICOL SCI, V46, P1